Your browser doesn't support javascript.
loading
Practical telehealth to improve control and engagement for patients with clinic-refractory diabetes mellitus (PRACTICE-DM): Protocol and baseline data for a randomized trial.
Kobe, Elizabeth A; Edelman, David; Tarkington, Phillip E; Bosworth, Hayden B; Maciejewski, Matthew L; Steinhauser, Karen; Jeffreys, Amy S; Coffman, Cynthia J; Smith, Valerie A; Strawbridge, Elizabeth M; Szabo, Steven T; Desai, Shivan; Garrett, Mary P; Wilmot, Theresa C; Marcano, Teresa J; Overby, Donna L; Tisdale, Glenda A; Durkee, Melissa; Bullard, Susan; Dar, Moahad S; Mundy, Amy C; Hiner, Janette; Fredrickson, Sonja K; Majette Elliott, Nadya T; Howard, Teresa; Jeter, Deborah H; Danus, Susanne; Crowley, Matthew J.
Afiliação
  • Kobe EA; Duke University School of Medicine, Durham, NC, United States of America.
  • Edelman D; Durham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Change (ADAPT), Durham, NC, United States of America; Division of General Internal Medicine, Department of Medicine, Duke University School of Medicine, Durham, NC, United States of America.
  • Tarkington PE; Central Virginia Veterans Affairs Health Care System, Richmond, VA, United States of America.
  • Bosworth HB; Durham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Change (ADAPT), Durham, NC, United States of America; Division of General Internal Medicine, Department of Medicine, Duke University School of Medicine, Durham, NC, United States of America; Department of Population He
  • Maciejewski ML; Durham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Change (ADAPT), Durham, NC, United States of America; Division of General Internal Medicine, Department of Medicine, Duke University School of Medicine, Durham, NC, United States of America; Department of Population He
  • Steinhauser K; Durham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Change (ADAPT), Durham, NC, United States of America.
  • Jeffreys AS; Durham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Change (ADAPT), Durham, NC, United States of America.
  • Coffman CJ; Durham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Change (ADAPT), Durham, NC, United States of America; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, United States of America.
  • Smith VA; Durham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Change (ADAPT), Durham, NC, United States of America; Division of General Internal Medicine, Department of Medicine, Duke University School of Medicine, Durham, NC, United States of America; Department of Population He
  • Strawbridge EM; Durham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Change (ADAPT), Durham, NC, United States of America.
  • Szabo ST; Durham Veterans Affairs Health Care System, Durham, NC, United States of America; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, United States of America; VA Mid-Atlantic Mental Illness, Research, Education and Clinical Center, Durham, NC, United States
  • Desai S; Central Virginia Veterans Affairs Health Care System, Richmond, VA, United States of America.
  • Garrett MP; Durham Veterans Affairs Health Care System, Durham, NC, United States of America.
  • Wilmot TC; Durham Veterans Affairs Health Care System, Durham, NC, United States of America.
  • Marcano TJ; Central Virginia Veterans Affairs Health Care System, Richmond, VA, United States of America.
  • Overby DL; Central Virginia Veterans Affairs Health Care System, Richmond, VA, United States of America.
  • Tisdale GA; Central Virginia Veterans Affairs Health Care System, Richmond, VA, United States of America.
  • Durkee M; Department of Pharmacy, Durham Veterans Affairs Health Care System, Durham, NC, United States of America.
  • Bullard S; Department of Pharmacy, Durham Veterans Affairs Health Care System, Durham, NC, United States of America.
  • Dar MS; Greenville VA Health Care Center, Greenville, NC, United States of America; Division of Endocrinology, Department of Medicine, Brody School of Medicine at East Carolina University, Greenville, NC, United States of America.
  • Mundy AC; Central Virginia Veterans Affairs Health Care System, Richmond, VA, United States of America.
  • Hiner J; Central Virginia Veterans Affairs Health Care System, Richmond, VA, United States of America.
  • Fredrickson SK; Central Virginia Veterans Affairs Health Care System, Richmond, VA, United States of America.
  • Majette Elliott NT; Durham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Change (ADAPT), Durham, NC, United States of America.
  • Howard T; Durham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Change (ADAPT), Durham, NC, United States of America.
  • Jeter DH; Central Virginia Veterans Affairs Health Care System, Richmond, VA, United States of America.
  • Danus S; Durham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Change (ADAPT), Durham, NC, United States of America.
  • Crowley MJ; Durham Veterans Affairs Center of Innovation to Accelerate Discovery and Practice Change (ADAPT), Durham, NC, United States of America; Division of Endocrinology, Department of Medicine, Duke University School of Medicine, Durham, NC, United States of America. Electronic address: matthew.crowley@duk
Contemp Clin Trials ; 98: 106157, 2020 11.
Article em En | MEDLINE | ID: mdl-32971277
ABSTRACT

BACKGROUND:

Persistent poorly-controlled type 2 diabetes mellitus (PPDM), or maintenance of a hemoglobin A1c (HbA1c) ≥8.5% despite receiving clinic-based diabetes care, contributes disproportionately to the national diabetes burden. Comprehensive telehealth interventions may help ameliorate PPDM, but existing approaches have rarely been designed with clinical implementation in mind, limiting use in routine practice. We describe a study testing a novel telehealth intervention that comprehensively targets clinic-refractory PPDM, and was explicitly developed for practical delivery using existing Veterans Health Administration (VHA) clinical infrastructure.

METHODS:

Practical Telehealth to Improve Control and Engagement for Patients with Clinic-Refractory Diabetes Mellitus (PRACTICE-DM) is an ongoing randomized controlled trial comparing two 12-month

interventions:

1) standard VHA Home Telehealth (HT) telemonitoring/care coordination; or 2) the PRACTICE-DM intervention, a comprehensive HT-delivered intervention combining telemonitoring, self-management support, diet/activity support, medication management, and depression management. The primary outcome is HbA1c. Secondary outcomes include diabetes distress, self-care, self-efficacy, weight, depressive symptoms, implementation barriers/facilitators, and costs. We hypothesize that the PRACTICE-DM intervention will reduce HbA1c by >0.6% versus standard HT over 12 months.

RESULTS:

Enrollment for this ongoing trial concluded in January 2020; 200 patients were randomized (99 to standard HT and 101 to the PRACTICE-DM intervention). The cohort has a mean age of 58 and is 23% female and 72% African American. Mean baseline HbA1c and BMI were 10.2% and 34.8 kg/m2.

CONCLUSIONS:

Because it comprehensively targets factors underlying PPDM using existing clinical infrastructure, the PRACTICE-DM intervention may be well suited to lower the complications and costs of PPDM in routine practice.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Telemedicina / Diabetes Mellitus Tipo 2 Tipo de estudo: Clinical_trials / Guideline Limite: Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Telemedicina / Diabetes Mellitus Tipo 2 Tipo de estudo: Clinical_trials / Guideline Limite: Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article